Induction of HITS, a newly identified family with sequence similarity 107 protein (FAM107B), in cancer cells by heat shock stimulation

International Journal of Oncology

Volumn 37, Issue 3, 2010, Pages 583-593

  Nakajima, Hideo ^a   Ishigaki, Yasuhito ^a   Xia, Qi Sheng ^a   Ikeda, Takayuki ^a   Yoshitake, Yoshino ^a   Yonekura, Hideto ^a   Nojima, Takayuki ^a   Tanaka, Takuji ^a   Umehara, Hisanori ^a   Tomosugi, Naohisa ^a   Takata, Takanobu ^a   Shimasaki, Takeo ^a   Nakaya, Naoki ^a   Sato, Itaru ^a   Kawakami, Kazuyuki ^b   Koizumi, Keita ^b   Minamoto, Toshinari ^b   Motoo, Yoshiharu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

FAM107; Heat shock protein; TU3A; Tumor suppressor gene

Indexed keywords

AZOXYMETHANE; HEAT SHOCK INDUCIBLE TUMOR SMALL PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER CELL; COLON; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; LUNG; LYMPHOID TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STOMACH; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE MODELS, ANIMAL; HEAT-SHOCK PROTEINS; HEAT-SHOCK RESPONSE; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; MALE; MICE; MICE, INBRED ICR; NEOPLASMS; TRANSFECTION;

EID: 77956544164     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000707     Document Type: Article

References (46)

1. Yamato T, Orikasa K, Fukushige S, Orikasa S and Horii A: Isolation and characterization of the novel gene, TU3A, in a commonly deleted region on 3p14.3-p14.2 in renal cell carcinoma. Cytogenet Cell Genet 87: 291-295, 1999. (Pubitemid 30103119)
2. Wang L, Darling J, Zhang JS, et al: Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chromosomes Cancer 27: 1-10, 2000.
3. Awakura Y, Nakamura E, Ito N, Kamoto T and Ogawa O: Methylation- associated silencing of TU3A in human cancers. Int J Oncol 33: 893-899, 2008.
4. Van den Boom J, Wolter M, Blaschke B, Knobbe CB and Reifenberger G: Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription- polymerase chain reaction. Int J Cancer 119: 2330-2338, 2006.
5. Vanaja DK, Ballman KV, Morlan BW, et al: PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clin Cancer Res 12: 1128-1136, 2006.
6. Liu Q, Zhao XY, Bai RZ, et al: Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1. Oncol Rep 22: 1069-1075, 2009.
7. Jolly C and Morimoto RI: Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92: 1564-1572, 2000.
8. Whitesell L and Lindquist SL: HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-772, 2005.
9. Mai W, Kawakami K, Shakoori A, et al: Deregulated GSK3, sustains gastrointestinal cancer cells survival by modulating human telomerase reverse transcriptase and telomerase. Clin Cancer Res 15: 6810-6819, 2009.
10. Jass JR, Sobin LH and Watanabe H: The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer 66: 2162-2167, 1990.
11. Shibata A, Longacre TA, Puligandla B, Parsonnet J and Habel LA: Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists. Cancer Epidemiol Biomarkers Prev 10: 75-78, 2001. (Pubitemid 32106048)
12. Suzuki R, Kohno H, Sugie S and Tanaka T: Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci 95: 721-727, 2004.
13. Ougolkov A, Zhang B, Yamashita K, et al: Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer. J Natl Cancer Inst 96: 1161-1170, 2004.
14. Nakajima H, Asai A, Okada A, et al: Transcriptional regulation of ILT family receptors. J Immunol 171: 6611-6620, 2003. (Pubitemid 37532093)
15. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
16. Van der Zee J: Heating the patient: a promising approach? Ann Oncol 13: 1173-1184, 2002.
17. Kholodnyuk ID, Kozireva S, Kost-Alimova M, Kashuba V, Klein G and Imreh S: Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer 119: 99-107, 2006.
18. Zhao XY, Liang SF, Yao SH, et al: Identification and preliminary function study of xenopus laevis DRR1 gene. Biochem Biophys Res Commun 361: 74-78, 2007.
19. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
20. Rubinfeld B, Souza B, Albert I, et al: Association of the APC gene product with β-catenin. Science 262: 1731-1734, 1993.
21. Fodde R, Kuipers J, Rosenberg C, et al: Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3: 433-438, 2001.
22. Grady WM and Markowitz SD: Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3: 101-128, 2002. (Pubitemid 35217432)
23. Rajagopalan H, Nowak MA, Vogelstein B and Lengauer C: The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3: 695-701, 2003.
24. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735-6740, 1992.
25. El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
26. Machado JC, Figueiredo C, Canedo P, et al: A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125: 364-371, 2003.
27. Guilford P, Hopkins J, Harraway J, et al: E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405, 1998. (Pubitemid 28168738)
28. Kim IJ, Kang HC, Shin Y, et al: A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J Hum Genet 49: 591-595, 2004.
29. Oliveira C, Ferreira P, Nabais S, et al: E-cadherin (cdh1) and p53 rather than Smad4 and caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 40: 1897-1903, 2004.
30. Kawamura H, Kondo Y, Osawa S, et al: A clinicopathologic study of mucinous adenocarcinoma of the stomach. Gastric Cancer 4: 83-86, 2001.
31. Perez RO, Bresciani BH, Bresciani C, et al: Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. Int J Colorectal Dis 23: 757-765, 2008.
32. Xie L, Villeneuve PJ and Shaw A: Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada. Int J Oncol 34: 1109-1115, 2009.
33. Wust P, Hildebrandt B, Sreenivasa G, et al: Hyperthermia in combined treatment of cancer. Lancet Oncol 3: 487-497, 2002.
34. Wegele H, Muller L and Buchner J: Hsp70 and hsp90-a relay team for protein folding. Rev Physiol Biochem Pharmacol 151: 1-44, 2004.
35. Takayama S, Reed JC and Homma S: Heat-shock proteins as regulators of apoptosis. Oncogene 22: 9041-9047, 2003.
36. Rohde M, Daugaard M, Jensen MH, Helin K, Nylandsted J and Jaattela M: Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms. Genes Dev 19: 570-582, 2005. (Pubitemid 40314989)
37. Jameel A, Skilton RA, Campbell TA, Chander SK, Coombes RC and Luqmani YA: Clinical and biological significance of HSP89 alpha in human breast cancer. Int J Cancer 50: 409-415, 1992.
38. Yano M, Naito Z, Tanaka S and Asano G: Expression and roles of heat shock proteins in human breast cancer. Jpn J Cancer Res 87: 908-915, 1996.
39. Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ and McGuire WL: Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst 85: 570-574, 1993.
40. Nanbu K, Konishi I, Mandai M, et al: Prognostic significance of heat shock proteins hsp70 and hsp90 in endometrial carcinomas. Cancer Detect Prev 22: 549-555, 1998.
41. Trieb K, Gerth R, Holzer G, Grohs JG, Berger P and Kotz R: Antibodies to heat shock protein 90 in osteosarcoma patients correlate with response to neoadjuvant chemotherapy. Br J Cancer 82: 85-87, 2000. (Pubitemid 30008963)
42. Foster CS, Dodson AR, Ambroisine L, et al: Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ets-gene rearrangement. Br J Cancer 101: 1137-1144, 2009.
43. Westwood JT, Clos J and Wu C: Stress-induced oligomerization and chromosomal relocalization of heat-shock factor. Nature 353: 822-827, 1991. (Pubitemid 21912629)
44. Dai C, Whitesell L, Rogers AB and Lindquist S: Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130: 1005-1018, 2007.
45. Min JN, Huang L, Zimonjic DB, Moskophidis D and Mivechi NF: Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 26: 5086-5097, 2007.
46. Zhao YH, Zhou M, Liu H, et al: Upregulation of lactate dehydrogenase a by erbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene 28: 3689-3701, 2009.